These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 218503)

  • 21. Evaluation of the anticomplement immunofluorescence test for detection of antibody to varicella-zoster virus.
    Preissner CM; Steinberg SP; Gershon AA; Smith TF
    J Clin Microbiol; 1982 Aug; 16(2):373-6. PubMed ID: 6288766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement fixing antibody to varicella-zoster virus in cancerous patients.
    Peserico A; Moschen ME; Romano M; Cartei G; Crivellari D; Trivello R
    Boll Ist Sieroter Milan; 1979 Sep; 58(4):335-8. PubMed ID: 233341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Varicella-zoster virus].
    Yamashita T; Osai Y; Nishizaka N; Hida T
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():310-3. PubMed ID: 20942066
    [No Abstract]   [Full Text] [Related]  

  • 24. Simultaneous rise in complement-fixing antibodies against herpesvirus hominis and varicella-zostervirus in patients with chickenpox and shingles.
    Schaap GJ; Huisman J
    Arch Gesamte Virusforsch; 1968; 25(1):52-7. PubMed ID: 4306835
    [No Abstract]   [Full Text] [Related]  

  • 25. Maternally acquired varicella-zoster virus antibodies disappear at 6 months of age in prematurely born children.
    Akisu M; Yalaz M; Aksu G; Arslanoglu S; Genel F; Kutukculer N; Kultursay N
    Panminerva Med; 2003 Jun; 45(2):155-6. PubMed ID: 12855941
    [No Abstract]   [Full Text] [Related]  

  • 26. Varicella virus isolation from spinal ganglion.
    Shibuta H; Ishikawa T; Hondo R; Aoyama Y; Kurata K; Matumoto M
    Arch Gesamte Virusforsch; 1974; 45(4):382-5. PubMed ID: 4374161
    [No Abstract]   [Full Text] [Related]  

  • 27. Sensitivity of different assay systems for immunoglobulin M responses to varicella-zoster virus in reactivated infections (zoster).
    Schmidt NJ; Arvin AM
    J Clin Microbiol; 1986 May; 23(5):978-9. PubMed ID: 3011851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The etiologic agents of varicella and herpes zoster; serologic studies with the viruses as propagated in vitro.
    WELLER TH; WITTON HM
    J Exp Med; 1958 Dec; 108(6):869-90. PubMed ID: 13598817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated immunity to varicella-zoster virus demonstrated by lymphocyte transformation in herpes zoster.
    Hata S
    J Dermatol; 1983 Feb; 10(1):13-6. PubMed ID: 6306084
    [No Abstract]   [Full Text] [Related]  

  • 30. Complement-fixing antigens produced by varicella-zoster virus in tissue culture.
    Martin ML; Palmer EL
    Appl Microbiol; 1973 Sep; 26(3):410-6. PubMed ID: 4356464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunological response of patients with herpes zoster (author's transl)].
    Higa K
    Fukuoka Igaku Zasshi; 1982 Mar; 73(3):131-45. PubMed ID: 6286440
    [No Abstract]   [Full Text] [Related]  

  • 32. Zoster immune globulin. A further assessment.
    Gershon AA; Steinberg S; Brunell PA
    N Engl J Med; 1974 Jan; 290(5):243-5. PubMed ID: 4358055
    [No Abstract]   [Full Text] [Related]  

  • 33. [Complement-binding antibody level in herpes zoster patients].
    Hata S
    Uirusu; 1974 Apr; 24(1):83-4. PubMed ID: 4478245
    [No Abstract]   [Full Text] [Related]  

  • 34. Complement fixing antibody to varicella-zoster virus in different age groups.
    Hata S
    J Dermatol; 1979 Jun; 6(3):197-200. PubMed ID: 231058
    [No Abstract]   [Full Text] [Related]  

  • 35. [An immunological study of herpes zoster patients III--specific immunity (author's transl)].
    Vacek Z; Trlifajová J; Doutlík S; Vasícková M; Ryba M
    Cesk Dermatol; 1981 Feb; 56(1):11-6. PubMed ID: 6260390
    [No Abstract]   [Full Text] [Related]  

  • 36. Cell-mediated and humoral immunity to herpesviruses during and after herpes zoster infections.
    Sørensen OS; Haahr S; Møller-Larsen A; Wildenhoff K
    Infect Immun; 1980 Aug; 29(2):369-75. PubMed ID: 6163709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility to varicella-zoster virus in Thai children and young adults.
    Kositanont U; Wasi C; Oonsombat P; Suvatte V; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):414-20. PubMed ID: 3006266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration of viral antibody activity in two immunoglobulin G subclasses in patients with varicella-zoster virus infection.
    Leonard LL; Schmidt NJ; Lennette EH
    J Immunol; 1970 Jan; 104(1):23-7. PubMed ID: 4189103
    [No Abstract]   [Full Text] [Related]  

  • 39. Virological course of herpes zoster in otherwise normal hosts.
    Cevenini R; Donati M; Rumpianesi F; Moroni A; Tosti A; Patrizi A; Varotti C; Negosanti M
    J Med Microbiol; 1983 Aug; 16(3):303-8. PubMed ID: 6308258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic tests: Varicella-zoster virus].
    Yamashita T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():294-6. PubMed ID: 16111254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.